Institutional Sign In

Go

Teta Drogerie a Lekarny

Profit Statement 2019 2020 2021
Sales CZK mil 5,623 5,828 5,720
Gross Profit CZK mil 831 762 799
EBITDA CZK mil 146 88.8 185
EBIT CZK mil -24.3 -28.6 115
Financing Cost CZK mil 14.6 4.43 0
Pre-Tax Profit CZK mil -40.5 -35.6 111
Net Profit CZK mil -41.5 -27.8 86.7
Balance Sheet 2019 2020 2021
Total Assets CZK mil 2,230 2,209 1,964
Non-Current Assets CZK mil 334 266 202
Current Assets CZK mil 1,843 1,892 1,698
Working Capital CZK mil 661 -19.4 107
Shareholders' Equity CZK mil 19.5 1.31 88.0
Liabilities CZK mil 2,211 2,207 1,876
Total Debt CZK mil 698 0.597 0.483
Net Debt CZK mil 664 -45.7 -34.4
Ratios 2019 2020 2021
ROE % -90.7 -266 194
ROCE % -4.96 -4.47 31.2
Gross Margin % 14.8 13.1 14.0
EBITDA Margin % 2.60 1.52 3.24
EBIT Margin % -0.433 -0.492 2.00
Net Margin % -0.739 -0.476 1.51
Net Debt/EBITDA 4.54 -0.515 -0.186
Net Debt/Equity % 3,396 -3,500 -39.1
Cost of Financing % 2.37 1.27 0
Cash Flow 2019 2020 2021
Total Cash From Operations CZK mil -121 42.0 -6.87
Total Cash From Investing CZK mil -61.1 -39.4 -4.42
Total Cash From Financing CZK mil 162 9.59 -0.114
Net Change In Cash CZK mil -19.6 12.2 -11.4
Cash Conversion Cycle days 47.4 -3.92 5.94
Cash Earnings CZK mil 129 89.6 157
Free Cash Flow CZK mil -182 2.62 -11.3

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2018 2019 2020 2021
income statement        
Sales CZK mil 5,525 5,623    
Gross Profit CZK mil 820 831    
EBIT CZK mil -3.54 -24.3    
Net Profit CZK mil -11.8 -41.5    
           
ROE % ... -90.7    
EBIT Margin % -0.064 -0.433    
Net Margin % -0.214 -0.739    
Employees 2,384 2,415    
balance sheet        
Total Assets CZK mil 2,443 2,230    
Non-Current Assets CZK mil 433 334    
Current Assets CZK mil 1,810 1,843    
           
Shareholders' Equity CZK mil 72.1 19.5    
Liabilities CZK mil 2,371 2,211    
Non-Current Liabilities CZK mil 1.61 0.534    
Current Liabilities CZK mil 2,253 2,079    
           
Net Debt/EBITDA 2.27 4.54    
Net Debt/Equity % 669 3,396    
Cost of Financing % ... 2.37    
cash flow        
Total Cash From Operations CZK mil 242 -121    
Total Cash From Investing CZK mil -88.8 -61.1    
Total Cash From Financing CZK mil -146 162    
Net Change In Cash CZK mil 7.90 -19.6    
income statement Unit 2018 2019 2020 2021
income statement        
Sales CZK mil 5,525 5,623    
Cost of Goods & Services CZK mil 4,705 4,792    
Gross Profit CZK mil 820 831    
Staff Cost CZK mil 804 844    
Other Operating Cost (Income) CZK mil -200 -184    
EBITDA CZK mil 212 146    
Depreciation CZK mil 216 171    
EBIT CZK mil -3.54 -24.3    
Net Financing Cost CZK mil 9.84 16.2    
Financing Cost CZK mil 8.95 14.6    
Financing Income CZK mil 1.47 0.981    
Extraordinary Cost CZK mil 0 0    
Pre-Tax Profit CZK mil -13.4 -40.5    
Tax CZK mil -1.56 1.02    
Minorities CZK mil 0 0    
Net Profit CZK mil -11.8 -41.5    
Net Profit Avail. to Common CZK mil -11.8 -41.5    
growth rates        
Total Revenue Growth % ... 1.76    
Staff Cost Growth % ... 4.96    
EBITDA Growth % ... -31.2    
EBIT Growth % ... 587    
Pre-Tax Profit Growth % ... 203    
Net Profit Growth % ... 252    
ratios        
ROE % ... -90.7    
ROA % ... -1.78    
ROCE % ... -4.96    
Gross Margin % 14.8 14.8    
EBITDA Margin % 3.85 2.60    
EBIT Margin % -0.064 -0.433    
Net Margin % -0.214 -0.739    
Cost of Financing % ... 2.37    
Net Debt/EBITDA 2.27 4.54    
balance sheet Unit 2018 2019 2020 2021
balance sheet        
Cash & Cash Equivalents CZK mil 53.7 34.1    
Receivables CZK mil 241 268    
Inventories CZK mil 1,515 1,540    
Current Assets CZK mil 1,810 1,843    
Property, Plant & Equipment CZK mil 433 334    
LT Investments & Receivables CZK mil 0 0    
Intangible Assets CZK mil 0.054 0.011    
Goodwill CZK mil 0 0    
Non-Current Assets CZK mil 433 334    
Total Assets CZK mil 2,443 2,230    
           
Trade Payables CZK mil 1,509 1,147    
Short-Term Debt CZK mil 534 697    
Other ST Liabilities CZK mil 209 234    
Current Liabilities CZK mil 2,253 2,079    
Long-Term Debt CZK mil 1.61 0.534    
Other LT Liabilities CZK mil 0 0    
Non-Current Liabilities CZK mil 1.61 0.534    
Liabilities CZK mil 2,371 2,211    
Equity Before Minority Interest CZK mil 72.1 19.5    
Minority Interest CZK mil 0 0    
Equity CZK mil 72.1 19.5    
growth rates        
Total Asset Growth % ... -8.71    
Shareholders' Equity Growth % ... -72.9    
Net Debt Growth % ... 37.6    
Total Debt Growth % ... 30.2    
ratios        
Total Debt CZK mil 536 698    
Net Debt CZK mil 482 664    
Working Capital CZK mil 247 661    
Capital Employed CZK mil 680 996    
Net Debt/Equity % 669 3,396    
Current Ratio 0.804 0.886    
Quick Ratio 0.131 0.145    
cash flow Unit 2018 2019 2020 2021
cash flow        
Net Profit CZK mil -11.8 -41.5    
Depreciation CZK mil 216 171    
Non-Cash Items CZK mil ... 164    
Change in Working Capital CZK mil ... -414    
Total Cash From Operations CZK mil 242 -121    
           
Capital Expenditures CZK mil -93.2 -70.7    
Other Investing Activities CZK mil 4.35 9.58    
Total Cash From Investing CZK mil -88.8 -61.1    
           
Dividends Paid CZK mil 0 0    
Issuance Of Shares CZK mil 0 0    
Issuance Of Debt CZK mil -146 162    
Total Cash From Financing CZK mil -146 162    
Net Change In Cash CZK mil 7.90 -19.6    
ratios        
Days Sales Outstanding days 15.9 17.4    
Days Sales Of Inventory days 118 117    
Days Payable Outstanding days 117 87.4    
Cash Conversion Cycle days 16.4 47.4    
Cash Earnings CZK mil 204 129    
Free Cash Flow CZK mil 154 -182    
Capital Expenditures (As % of Sales) % 1.69 1.26    
other ratios Unit 2018 2019 2020 2021
         
Employees 2,384 2,415    
Cost Per Employee USD per month 1,285 1,292    
Cost Per Employee (Local Currency) CZK per month 28,119 29,134    
Material & Energy (As % of Sales) % 70.0 69.9    
Services (As % of Sales) % 15.2 15.4    
Staff Cost (As % of Sales) % 14.6 15.0    
Effective Tax Rate % 11.7 -2.51    

Get all company financials in excel:

Download Sample   $19.99

Teta Drogerie a Lekarny Logo

Finance

Teta Drogerie a Lekarny has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of CZK 185 mil in 2021, or 3.24% of sales. That’s compared to 2.80% average margin seen in last five years.

The company netted CZK 86.7 mil in 2021 implying ROE of 194% and ROCE of 31.2%. Again, the average figures were -54.3% and 7.26%, respectively when looking at the previous 5 years.

Teta Drogerie a Lekarny’s net debt amounted to CZK -34.4 mil at the end of 2021, or -39.1% of equity. When compared to EBITDA, net debt was -0.186x, down when compared to average of 1.53x seen in the last 5 years.